Cash flow statement
for the period ended 30 June 2019
|
Original budget |
||||
|
2019 |
2018 |
2019 |
||
|
Notes |
$ |
$ |
$ |
|
|
OPERATING ACTIVITIES |
||||
|
Cash received |
||||
|
Appropriations |
12,544,000 |
12,420,000 |
12,758,000 |
|
|
Sales of goods and rendering of services |
8,260,087 |
7,901,916 |
6,898,000 |
|
|
Other cash received |
4,387,920 |
4,300,519 |
4,396,000 |
|
|
GST received |
548,069 |
191,132 |
456,000 |
|
|
Total cash received |
25,740,076 |
24,813,567 |
24,508,000 |
|
|
Cash used |
||||
|
Employees |
(16,944,928) |
(17,049,713) |
(16,494,000) |
|
|
Suppliers |
(8,692,624) |
(8,403,685) |
(7,591,000) |
|
|
GST paid |
- |
- |
(423,000) |
|
|
Total cash used |
(25,637,552) |
(25,453,398) |
(24,508,000) |
|
|
Net cash (used by) / from operating activities |
102,524 |
(639,831) |
- |
|
|
INVESTING ACTIVITIES |
||||
|
Cash used |
||||
|
Purchase of property, plant, equipment and intangibles |
(5,986,876) |
(2,253,353) |
(1,945,000) |
|
|
Total cash used |
(5,986,876) |
(2,253,353) |
(1,945,000) |
|
|
Net cash (used by) investing activities |
(5,986,876) |
(2,253,353) |
(1,945,000) |
|
|
FINANCING ACTIVITIES |
||||
|
Cash received |
||||
|
Contributed equity - Departmental capital budget |
2,330,000 |
1,651,000 |
1,945,000 |
|
|
Contributed equity - Equity injection |
3,800,000 |
1,200,000 |
- |
|
|
Total cash received |
6,130,000 |
2,851,000 |
1,945,000 |
|
|
Net cash from financing activities |
6,130,000 |
2,851,000 |
1,945,000 |
|
|
Net (decrease) / increase in cash held |
245,648 |
(42,184) |
0 |
|
|
Cash and cash equivalents at the beginning of the reporting period |
1,100,443 |
1,142,627 |
1,143,000 |
|
|
Cash and cash equivalents at the end of the reporting period |
1,346,091 |
1,100,443 |
1,143,000 |
The above statement should be read in conjunction with the accompanying notes.
Budget variances commentary
Cash flow statement
The above table provides a comparison between the 2018–19 Portfolio Budget Statements (PBS) budget and the final financial outcome in the 2018–19 financial statements. The Budget is not audited and does not reflect additional budget estimates provided in the 2018–19 Portfolio Additional Estimates Statements (PAES) or the revised budget provided as part of the 2019–2020 Portfolio Budget Statements (PBS). However major changes in budget have been explained as part of the variance analysis where relevant.
The actuals are prepared in accordance with Australian Accounting Standards.
Explanations have been provided where movements are greater than 10% of the line item and/or 2% of total cash received or used unless the movement is clearly trivial.
Departmental major budget variances for 2019
|
Explanations of major variances |
Affected line items (and statement) |
|||||
|
Variances relating to cash flows occur because of the factors detailed under expenses, own source income, assets or liabilities. |
Operating, investing, financing activities (cash flow statement) |
|||||
|
Investing activities - cash used |
||||||
|
The increase in expenditure related to the medical linear accelerator project, completed during the year. |
Investing, financing activities (cash flow statement) |
|||||
|
Contributed equity |
||||||
|
Variance of $4,185,000 for the current year relates to the drawdown of prior year appropriation, mainly associated with the medical linear accelerator project |
Financing activities (cash flow statement), trade and other receivables (statement of financial position) |
|||||
Visit
https://www.transparency.gov.au/annual-reports/australian-radiation-protection-and-nuclear-safety-agency/reporting-year/2018-2019-36